1
|
Li YY: Genetic and epigenetic variants
influencing the development of nonalcoholic fatty liver disease.
World J Gastroenterol. 18:6546–6551. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yokoyama C, Wang X, Briggs MR, et al:
SREBP-1, a basic-helix-loop-helix-leucine zipper protein that
controls transcription of the low density lipoprotein receptor
gene. Cell. 75:187–197. 1993. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jeon TI and Osborne TF: SREBPs: metabolic
integrators in physiology and metabolism. Trends Endocrinol Metab.
23:65–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lewis CA, Griffiths B, Santos CR, et al:
Genetic ablation of S6-kinase does not prevent processing of
SREBP1. Adv Enzyme Regul. 51:280–290. 2011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rudolph MC, Monks J, Burns V, et al:
Sterol regulatory element binding protein and dietary lipid
regulation of fatty acid synthesis in the mammary epithelium. Am J
Physiol Endocrinol Metab. 299:E918–E927. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Matthews KA, Ozdemir C and Rawson RB:
Activation of sterol regulatory element binding proteins in the
absence of Scap in Drosophila melanogaster. Genetics.
185:189–198. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sampath H, Miyazaki M, Dobrzyn A, et al:
Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of
dietary saturated fat. J Biol Chem. 282:2483–2493. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Israël M and Schwartz L: The metabolic
advantage of tumor cells. Mol Cancer. 10:702010.
|
9
|
Swinnen JV, Brusselmans K and Verhoeven G:
Increased lipogenesis in cancer cells: new players, novel targets.
Curr Opin Clin Nutr Metab Care. 9:358–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Horie T, Ono K, Horiguchi M, et al:
MicroRNA-33 encoded by an intron of sterol regulatory
element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl
Acad Sci USA. 107:17321–17326. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Dávalos A, Goedeke L, Smibert P, et al:
miR-33a/b contribute to the regulation of fatty acid metabolism and
insulin signaling. Proc Natl Acad Sci USA. 108:9232–9237.
2011.PubMed/NCBI
|
12
|
Rayner KJ, Esau CC, Hussain FN, et al:
Inhibition of miR-33a/b in non-human primates raises plasma HDL and
lowers VLDL triglycerides. Nature. 478:404–407. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Perez-Tilve D, Heppner K, Kirchner H, et
al: Ghrelin-induced adiposity is independent of orexigenic effects.
FASEB J. 25:2814–2822. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Weiss L, Hoffmann GE, Schreiber R, et al:
Fatty-acid biosynthesis in man, a pathway of minor importance.
Purification, optimal assay conditions, and organ distribution of
fatty-acid synthase. Biol Chem Hoppe Seyler. 367:905–912. 1986.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Kusakabe T, Maeda M, Hoshi N, et al: Fatty
acid synthase is expressed mainly in adult hormone-sensitive cells
or cells with high lipid metabolism and in proliferating fetal
cells. J Histochem Cytochem. 48:613–622. 2000. View Article : Google Scholar : PubMed/NCBI
|
17
|
Najafi-Shoushtari SH, Kristo F, Li Y, et
al: MicroRNA-33 and the SREBP host genes cooperate to control
cholesterol homeostasis. Science. 328:1566–1569. 2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ramírez CM, Goedeke L and
Fernández-Hernando C: ‘Micromanaging’ metabolic syndrome. Cell
Cycle. 10:3249–3252. 2011.
|
19
|
Nohturfft A, DeBose-Boyd RA, Scheek S, et
al: Sterols regulate cycling of SREBP cleavage-activating protein
(SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci
USA. 96:11235–11240. 1999. View Article : Google Scholar : PubMed/NCBI
|